Manufacturer
GLAXOSMITHKLINE BIOLOGICALS S.A
Contents
Per 1 mL Inactivated HAV 720 ELISA U adsorbed, recombinant HBsAg 20 mcg adsorbed
Indication
Non-immune adult & childn ≥1 yr at risk of both hepatitis A & B infection.
Instruction
IM Adult & adolescent ≥16 yr 3 primary doses at 0, 1, 6 mth (standard schedule) or 0, 7, 21 days followed by 4th dose at 12 mth (rapid schedule). Childn 1-15 yr 2 primary doses at 0, 6-12 mth. Booster dose General guideline can be drawn from experience w/ the monovalent vaccines.
Drug interaction
Adequate response may not be achieved w/ immunosuppressants.
Malaysia
